Moderna
Search results
We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer, and infectious diseases and other serious diseases.
BioNTech was founded in 2008 based on research by Uğur Şahin, Özlem Türeci, [12] and Christoph Huber, [13] with a seed investment of €150 million from MIG Capital and AT Impf. [14] The company's activities focus on the development and production of technologies and drugs for individualized cancer immunotherapy. [3]
Nov 14, 2022 · SINGAPORE – BioNTech on Monday confirmed that its first mRNA manufacturing plant in Singapore will be operational in late 2023, with the facility also serving as the German company’s regional ...
Unsere Mission. Mit unserer Grundlagenforschung und der Entwicklung von Immuntherapien möchten wir die Gesundheit der Menschen weltweit verbessern, indem wir das volle Potenzial des Immunsystems nutzen, um Krebs und Infektionskrankheiten zu bekämpfen.
With decades of deep immunology expertise and experience in developing and optimizing mRNA as part of its broad suite of novel technologies, the company is working with the global community to defeat life-threatening and serious diseases such as cancer, COVID-19, malaria and tuberculosis.
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) Read more.
We aspire to find new and better ways to treat and prevent diseases. We aim to improve standards of care or establish new ones. We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer and infectious diseases.
Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals.
BioNTech is growing - and this creates a lot of career opportunities in research, development, operations, commercial roles and enabling functions. Learn more about our culture, benefits and locations and find the right job for you.
A transatlantic leader in individualized neoantigen-targeted T cell therapies. Based in Cambridge, MA, BioNTech US serves as BioNTech’s North American headquarters and is an important part of our global effort to pioneer the development of next-generation immuno-oncology therapies.
